Interim Chief Executive Officer
David VanVliet is Interim Chief Executive Officer for Pharma Tech Industries. He has assumed overall leadership of the company as industry veteran Tee Noland transitions to a new role as Pharma Tech’s Chairman of the Board.
David joins Pharma Tech Industries with more than 20 years of CEO and President-level experience spanning the healthcare and pharmaceutical sectors. Most recently, as President and CEO at Angelica, Inc. – a prominent supplier to thousands of hospitals, clinics and long-term care facilities – he successfully guided the company’s 4,000 employees and 26 production centers. David also has held leadership roles at notable companies including KV Pharmaceutical, Procter & Gamble, and Nabisco, Inc.
David graduated from Dartmouth College with a degree in economics and continued his graduate studies at George Washington University. He also has board experience at various public, private and non-profit organizations.